"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","contact_web_link","supplementary_file","data_row_count","relation"
"GSM712195","colorectal cancer sample C1018II [exon-level]","GSM712195","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712195/GSM712195_C1018II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712082 (gene-level analysis)"
"GSM712196","colorectal cancer sample C1022II [exon-level]","GSM712196","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-H","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712196/GSM712196_C1022II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712083 (gene-level analysis)"
"GSM712197","colorectal cancer sample C1030II_2 [exon-level]","GSM712197","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-L","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712197/GSM712197_C1030II_HuEx-1_0-st-v2_2.CEL.gz","284258","Alternative to: GSM712084 (gene-level analysis)"
"GSM712198","colorectal cancer sample C1033III [exon-level]","GSM712198","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 3.5","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712198/GSM712198_C1033III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712085 (gene-level analysis)"
"GSM712199","colorectal cancer sample C1034III [exon-level]","GSM712199","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.2","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712199/GSM712199_C1034III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712086 (gene-level analysis)"
"GSM712200","colorectal cancer sample C1043II [exon-level]","GSM712200","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712200/GSM712200_C1043II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712087 (gene-level analysis)"
"GSM712201","colorectal cancer sample C1049II [exon-level]","GSM712201","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 3.1","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712201/GSM712201_C1049II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712088 (gene-level analysis)"
"GSM712202","colorectal cancer sample C1065III [exon-level]","GSM712202","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 2.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712202/GSM712202_C1065III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712089 (gene-level analysis)"
"GSM712203","colorectal cancer sample C1068III [exon-level]","GSM712203","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 4.7","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712203/GSM712203_C1068III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712090 (gene-level analysis)"
"GSM712204","colorectal cancer sample C1077III [exon-level]","GSM712204","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712204/GSM712204_C1077III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712091 (gene-level analysis)"
"GSM712205","colorectal cancer sample C1085II [exon-level]","GSM712205","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712205/GSM712205_C1085II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712092 (gene-level analysis)"
"GSM712206","colorectal cancer sample C1089II [exon-level]","GSM712206","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712206/GSM712206_C1089II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712093 (gene-level analysis)"
"GSM712207","colorectal cancer sample C1091II [exon-level]","GSM712207","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-L","disease_specific_survival_event: 1","disease_specific_survival_years: 2.5","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712207/GSM712207_C1091II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712094 (gene-level analysis)"
"GSM712208","colorectal cancer sample C1102II [exon-level]","GSM712208","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 4.1","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712208/GSM712208_C1102II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712095 (gene-level analysis)"
"GSM712209","colorectal cancer sample C1112II [exon-level]","GSM712209","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712209/GSM712209_C1112II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712096 (gene-level analysis)"
"GSM712210","colorectal cancer sample C1118III [exon-level]","GSM712210","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712210/GSM712210_C1118III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712097 (gene-level analysis)"
"GSM712211","colorectal cancer sample C1135II [exon-level]","GSM712211","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712211/GSM712211_C1135II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712098 (gene-level analysis)"
"GSM712212","colorectal cancer sample C1142III [exon-level]","GSM712212","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.5","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712212/GSM712212_C1142III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712099 (gene-level analysis)"
"GSM712213","colorectal cancer sample C1144III [exon-level]","GSM712213","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 4.3","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712213/GSM712213_C1144III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712100 (gene-level analysis)"
"GSM712214","colorectal cancer sample C1145III [exon-level]","GSM712214","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.3","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712214/GSM712214_C1145III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712101 (gene-level analysis)"
"GSM712215","colorectal cancer sample C1152III [exon-level]","GSM712215","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712215/GSM712215_C1152III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712102 (gene-level analysis)"
"GSM712216","colorectal cancer sample C1156II [exon-level]","GSM712216","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712216/GSM712216_C1156II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712103 (gene-level analysis)"
"GSM712218","colorectal cancer sample C1159III [exon-level]","GSM712218","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712218/GSM712218_C1159III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712104 (gene-level analysis)"
"GSM712221","colorectal cancer sample C1190II [exon-level]","GSM712221","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-H","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712221/GSM712221_C1190II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712105 (gene-level analysis)"
"GSM712224","colorectal cancer sample C1198III [exon-level]","GSM712224","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712224/GSM712224_C1198III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712106 (gene-level analysis)"
"GSM712226","colorectal cancer sample C1251III [exon-level]","GSM712226","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712226/GSM712226_C1251III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712107 (gene-level analysis)"
"GSM712228","colorectal cancer sample C1257II [exon-level]","GSM712228","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: NA","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712228/GSM712228_C1257II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712108 (gene-level analysis)"
"GSM712231","colorectal cancer sample C1263II [exon-level]","GSM712231","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712231/GSM712231_C1263II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712109 (gene-level analysis)"
"GSM712234","colorectal cancer sample C1264II [exon-level]","GSM712234","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 6.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712234/GSM712234_C1264II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712110 (gene-level analysis)"
"GSM712237","colorectal cancer sample C1267III [exon-level]","GSM712237","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712237/GSM712237_C1267III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712111 (gene-level analysis)"
"GSM712238","colorectal cancer sample C1271III [exon-level]","GSM712238","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 0.7","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712238/GSM712238_C1271III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712112 (gene-level analysis)"
"GSM712241","colorectal cancer sample C1273II [exon-level]","GSM712241","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSI-H","disease_specific_survival_event: 1","disease_specific_survival_years: 7.7","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712241/GSM712241_C1273II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712113 (gene-level analysis)"
"GSM712243","colorectal cancer sample C1275III [exon-level]","GSM712243","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 4.1","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712243/GSM712243_C1275III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712114 (gene-level analysis)"
"GSM712245","colorectal cancer sample C1280III [exon-level]","GSM712245","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 2.8","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712245/GSM712245_C1280III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712115 (gene-level analysis)"
"GSM712248","colorectal cancer sample C1283II [exon-level]","GSM712248","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-H","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712248/GSM712248_C1283II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712116 (gene-level analysis)"
"GSM712251","colorectal cancer sample C1284III [exon-level]","GSM712251","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712251/GSM712251_C1284III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712117 (gene-level analysis)"
"GSM712253","colorectal cancer sample C1285III [exon-level]","GSM712253","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.4","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712253/GSM712253_C1285III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712118 (gene-level analysis)"
"GSM712255","colorectal cancer sample C1286III [exon-level]","GSM712255","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712255/GSM712255_C1286III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712119 (gene-level analysis)"
"GSM712257","colorectal cancer sample C1291II [exon-level]","GSM712257","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712257/GSM712257_C1291II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712120 (gene-level analysis)"
"GSM712258","colorectal cancer sample C1292III [exon-level]","GSM712258","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712258/GSM712258_C1292III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712121 (gene-level analysis)"
"GSM712259","colorectal cancer sample C1294II [exon-level]","GSM712259","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 3.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712259/GSM712259_C1294II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712122 (gene-level analysis)"
"GSM712260","colorectal cancer sample C1296II [exon-level]","GSM712260","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 2.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712260/GSM712260_C1296II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712123 (gene-level analysis)"
"GSM712261","colorectal cancer sample C1301III [exon-level]","GSM712261","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712261/GSM712261_C1301III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712124 (gene-level analysis)"
"GSM712262","colorectal cancer sample C1308III [exon-level]","GSM712262","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712262/GSM712262_C1308III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712125 (gene-level analysis)"
"GSM712263","colorectal cancer sample C1314III [exon-level]","GSM712263","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-H","disease_specific_survival_event: 1","disease_specific_survival_years: 5.2","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712263/GSM712263_C1314III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712126 (gene-level analysis)"
"GSM712264","colorectal cancer sample C1321II [exon-level]","GSM712264","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 3.8","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712264/GSM712264_C1321II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712127 (gene-level analysis)"
"GSM712265","colorectal cancer sample C1323III [exon-level]","GSM712265","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 5.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712265/GSM712265_C1323III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712128 (gene-level analysis)"
"GSM712266","colorectal cancer sample C1330III [exon-level]","GSM712266","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712266/GSM712266_C1330III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712129 (gene-level analysis)"
"GSM712267","colorectal cancer sample C1333III [exon-level]","GSM712267","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 5.5","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712267/GSM712267_C1333III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712130 (gene-level analysis)"
"GSM712268","colorectal cancer sample C1334III [exon-level]","GSM712268","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 2.3","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712268/GSM712268_C1334III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712131 (gene-level analysis)"
"GSM712269","colorectal cancer sample C1340III [exon-level]","GSM712269","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-L","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712269/GSM712269_C1340III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712132 (gene-level analysis)"
"GSM712270","colorectal cancer sample C1356III [exon-level]","GSM712270","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712270/GSM712270_C1356III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712133 (gene-level analysis)"
"GSM712271","colorectal cancer sample C1357II [exon-level]","GSM712271","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-L","disease_specific_survival_event: 1","disease_specific_survival_years: 1.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712271/GSM712271_C1357II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712134 (gene-level analysis)"
"GSM712272","colorectal cancer sample C1364II [exon-level]","GSM712272","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712272/GSM712272_C1364II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712135 (gene-level analysis)"
"GSM712273","colorectal cancer sample C1379II [exon-level]","GSM712273","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 2.9","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712273/GSM712273_C1379II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712136 (gene-level analysis)"
"GSM712274","colorectal cancer sample C1380III [exon-level]","GSM712274","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 8.1","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712274/GSM712274_C1380III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712137 (gene-level analysis)"
"GSM712275","colorectal cancer sample C1389III [exon-level]","GSM712275","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 4.8","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712275/GSM712275_C1389III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712138 (gene-level analysis)"
"GSM712276","colorectal cancer sample C1391II [exon-level]","GSM712276","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712276/GSM712276_C1391II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712139 (gene-level analysis)"
"GSM712277","colorectal cancer sample C1393III [exon-level]","GSM712277","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 5.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712277/GSM712277_C1393III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712140 (gene-level analysis)"
"GSM712278","colorectal cancer sample C1395II [exon-level]","GSM712278","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712278/GSM712278_C1395II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712141 (gene-level analysis)"
"GSM712279","colorectal cancer sample C1402III [exon-level]","GSM712279","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712279/GSM712279_C1402III_HuEx-1_0-st-v2_3.CEL.gz","284258","Alternative to: GSM712142 (gene-level analysis)"
"GSM712280","colorectal cancer sample C861y [exon-level]","GSM712280","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.6","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712280/GSM712280_C861y_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712143 (gene-level analysis)"
"GSM712281","colorectal cancer sample C891II [exon-level]","GSM712281","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-L","disease_specific_survival_event: 1","disease_specific_survival_years: 1.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712281/GSM712281_C891II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712144 (gene-level analysis)"
"GSM712282","colorectal cancer sample C895II [exon-level]","GSM712282","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712282/GSM712282_C895II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712145 (gene-level analysis)"
"GSM712283","colorectal cancer sample C896III [exon-level]","GSM712283","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 2.5","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712283/GSM712283_C896III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712146 (gene-level analysis)"
"GSM712284","colorectal cancer sample C914III [exon-level]","GSM712284","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712284/GSM712284_C914III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712147 (gene-level analysis)"
"GSM712285","colorectal cancer sample C932III [exon-level]","GSM712285","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712285/GSM712285_C932III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712148 (gene-level analysis)"
"GSM712286","colorectal cancer sample C935II [exon-level]","GSM712286","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712286/GSM712286_C935II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712149 (gene-level analysis)"
"GSM712287","colorectal cancer sample C937III [exon-level]","GSM712287","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712287/GSM712287_C937III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712150 (gene-level analysis)"
"GSM712288","colorectal cancer sample C940III [exon-level]","GSM712288","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 5.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712288/GSM712288_C940III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712151 (gene-level analysis)"
"GSM712289","colorectal cancer sample C946II [exon-level]","GSM712289","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 5.2","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712289/GSM712289_C946II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712152 (gene-level analysis)"
"GSM712290","colorectal cancer sample C950II [exon-level]","GSM712290","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712290/GSM712290_C950II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712153 (gene-level analysis)"
"GSM712291","colorectal cancer sample C964II [exon-level]","GSM712291","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712291/GSM712291_C964II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712154 (gene-level analysis)"
"GSM712292","colorectal cancer sample C965II [exon-level]","GSM712292","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSI-H","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712292/GSM712292_C965II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712155 (gene-level analysis)"
"GSM712293","colorectal cancer sample C970II [exon-level]","GSM712293","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712293/GSM712293_C970II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712156 (gene-level analysis)"
"GSM712294","colorectal cancer sample C975III [exon-level]","GSM712294","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.2","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712294/GSM712294_C975III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712157 (gene-level analysis)"
"GSM712295","colorectal cancer sample C976II [exon-level]","GSM712295","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712295/GSM712295_C976II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712158 (gene-level analysis)"
"GSM712296","colorectal cancer sample C978II [exon-level]","GSM712296","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712296/GSM712296_C978II_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712159 (gene-level analysis)"
"GSM712297","colorectal cancer sample C980III [exon-level]","GSM712297","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-H","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712297/GSM712297_C980III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712160 (gene-level analysis)"
"GSM712298","colorectal cancer sample C981III [exon-level]","GSM712298","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 0","disease_specific_survival_years: 10.0","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712298/GSM712298_C981III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712161 (gene-level analysis)"
"GSM712299","colorectal cancer sample C982III [exon-level]","GSM712299","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSI-L","disease_specific_survival_event: 1","disease_specific_survival_years: 2.1","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712299/GSM712299_C982III_RUN2_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712162 (gene-level analysis)"
"GSM712300","colorectal cancer sample C983III [exon-level]","GSM712300","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 2","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 1.1","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712300/GSM712300_C983III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712163 (gene-level analysis)"
"GSM712301","colorectal cancer sample C985III [exon-level]","GSM712301","Public on May 19 2011","Apr 20 2011","May 19 2011","RNA","1","Colorectal cancer patient","Homo sapiens","tissue: colorectal cancer biopsy","tumor stage: 3","msi-status: MSS","disease_specific_survival_event: 1","disease_specific_survival_years: 0.8","total RNA","Total RNA was isolated from <30 mg colorectal cancer biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol.","biotin","Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","9606","Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)","Array scanning was performed according to the manufacturer's instruction (Affymetrix)","Alternative splicing score resulting from running the FIRMA algorithm implemented with an R code in the aroma.affymetrix Bioconductor package","For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).","GPL11028","Anita,,Sveen","anita.sveen@rr-research.no","Department of Cancer Prevention, Institute for Cancer Research","Oslo University Hospital, The Norwegian Radium Hospital","P.O.Box 4953, Nydalen","Oslo","NO-0424","Norway","http://www.ous-research.no/cancerprevention/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712301/GSM712301_C985III_HuEx-1_0-st-v2_.CEL.gz","284258","Alternative to: GSM712164 (gene-level analysis)"
